National Advocates for Pregnant Women Files Brief with U.S. Supreme Court Focusing on the Impact of Mississippi’s Abortion Ban on All Pregnant People, Not Only Those Seeking to End a Pregnancy

On September 20, 2021, National Advocates for Pregnant Women (NAPW), with co-counsel David Goldberg, partner at Donahue, Goldberg, and Littleton, filed an amicus curiae (friend of the court) brief in Dobbs v. Jackson Women’s Health Organization in support of Respondents’ challenge to Mississippi’s law banning abortion after 15 weeks of pregnancy.

NAPW’S Analysis of South Carolina S.1 and Mississippi HB 755

NAPW provides a unique and base-broadening perspective on anti-abortion legislation, including laws that seek to establish separate status for fertilized eggs, embryos, and fetuses. As a result, allies often ask (typically at the very last minute) for our analysis of proposed legislation that on the surface appears to impact only access to abortion or to have no impact on pregnant people at all.

Reproductive Justice and Anti Violence Statement Challenging False Claims Linking Laws Criminalizing Abortion and Related Feticide Laws with Protection of Women from Violence

Some reports following New York’s passage of the Reproductive Health Act (RHA) asserted that the RHA somehow increases the risk of gender violence. NAPW and Professor Julie Goldscheid (CUNY Law School) authored a statement challenging those claims, and other false claims linking laws criminalizing abortion and related feticide laws with protection of women from violence.

National Advocates for Pregnant Women and If/When/How Letter to FDA Opposing Restrictions on Abortion Medication

National Advocates for Pregnant Women and If/When/How wrote and organized a letter sent to the FDA, signed by organizations and experts in reproductive health and rights, public health, harm reduction, and HIV/AIDS. The letter opposes the recent warning letters targeting mifepristone and misoprostol as dangerous, and urges the FDA to remove the REMS for mife.